Live Breaking News & Updates on Treating Recurrent

Stay updated with breaking news from Treating recurrent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Live Microbiota Therapy Prevents Recurrent CDI in Older Adults with Comorbidity

New data presented at ACG 2023 showed an approximate 60% success rate of recurrent C difficile prevention in adults with comorbid conditions including CKD and cardiac disease. ....

British Columbia , Andrew Skinner , Cirlea Warren , American College Of Gastroenterology , Loyola University , University Of Virginia , American College , Scientific Meeting , Fecal Microbiota , Older Participants With Recurrent Clostridioides , Underlying Comorbidities , First Live Microbiota Treatment , Microbiome Based Therapies , Treating Recurrent , C Difficile , Acg 2023 , Phase 3 ,

Immune Modulator Addition Doesn't Boost Survival in Tough Thyroid Cancer

Despite initial promise, combining lenalidomide with cediranib didn t improve progression-free survival in differentiated thyroid cancer (DTC). ....

University Of Chicago Medicine Comprehensive Cancer Center , Chicago Medicine Comprehensive Cancer , Treating Recurrent , Metastatic Differentiated Thyroid Cancer , Differentiated Thyroid Cancer , Thyroid Cancer Treatment ,

Role of Live-JSLM in Treating Recurrent CDI

Joseph Reilly, BS, PharmD, BCGP, and Andrew Skinner, MD, discuss the potential benefits of using live-jslm early on to treat CDI, as well as the implications of this new treatment. ....

Joseph Reilly , Andrew Skinner , Microbiome Based Therapies , Treating Recurrent , C Difficile Infection , C Diff , Fecal Microbiota Transplantation , Recurrent Cdi , Live Jslm ,